tiprankstipranks
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market
XRTX
XORTX Therapeutics Inc
RESEARCH TOOLSreports

XORTX Therapeutics Inc (XRTX) Financial Statements

83 Followers

XORTX Therapeutics Inc Financial Overview

XORTX Therapeutics Inc's market cap is currently $3.68M. The company's EPS TTM is $-10.94; its P/E ratio is -0.19; XORTX Therapeutics Inc is scheduled to report earnings on May 16, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00C$ 0.00C$ 0.00
Gross Profit$ -114.08K$ -111.64K$ -141.96KC$ -75.27KC$ -17.88K
Operating Income$ -3.31M$ -3.92M$ -6.14MC$ -12.43MC$ -2.90M
EBITDA$ -3.20M$ -3.04M$ -6.00MC$ -9.41MC$ -2.90M
Net Income$ -2.70M-$ -2.86MC$ -6.99MC$ -1.65M
Balance Sheet
Cash & Short-Term Investments$ 862.94K$ 2.47M$ 3.45MC$ 10.43MC$ 18.80M
Total Assets$ 2.68M$ 4.09M$ 5.47MC$ 12.37MC$ 17.38M
Total Debt$ 37.22K$ 38.76K$ 11.51KC$ 77.60KC$ 0.00
Net Debt$ -825.72K$ -2.43M$ -3.44MC$ -10.36MC$ -14.87M
Total Liabilities$ 597.98K$ 757.54K$ 825.94KC$ 5.38MC$ 4.18M
Stockholders' Equity$ 2.08M$ 3.33M$ 4.64MC$ 7.00MC$ 13.20M
Cash Flow
Free Cash Flow$ -2.82M$ -3.50M$ -6.63MC$ -9.01MC$ -4.83M
Operating Cash Flow$ -2.82M$ -3.50M$ -6.58MC$ -8.96MC$ -4.80M
Investing Cash Flow$ -300.12K$ -38.92K$ -46.36KC$ -60.02KC$ -31.81K
Financing Cash Flow$ 1.45M$ 2.78M$ -361.04KC$ 6.43MC$ 19.37M

XORTX Therapeutics Inc Earnings and Revenue History

Income Statement >

XORTX Therapeutics Inc Debt to Assets

Balance Sheet >

XORTX Therapeutics Inc Cash Flow

Cash Flow >

XORTX Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >